Literature DB >> 20080467

Contribution of hypoxia-measuring molecular imaging techniques to radiotherapy planning and treatment.

Carlos Ferrer Albiach1, Antonio Conde Moreno, Marta Rodríguez Cordón, Virginia Morillo Macías, Ana Bouché Babiloni, Inmaculada Beato Tortajada, Angel Sánchez Iglesias, Alicia Francés Muñoz.   

Abstract

Hypoxia is related to poor prognosis because it is associated to chemo- and radioresistance. During recent years the evolution of imaging methods like PET/CT and MRI has meant the appearance of new perspectives with direct implications in radiation therapy. We discuss previous experiences in staging, planning and in the follow-up process with these techniques for measuring tumour hypoxia.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20080467     DOI： 10.1007/s12094-010-0462-3

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


  38 in total

Review 1.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

2.  Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.

Authors:  Matthias Bache; Rolf Reddemann; Harun M Said; Hans-Jürgen Holzhausen; Helge Taubert; Axel Becker; Thomas Kuhnt; Gabriele Hänsgen; Jürgen Dunst; Dirk Vordermark
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-10-23       Impact factor: 7.038

3.  Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent.

Authors:  Rodney J Hicks; Danny Rischin; Richard Fisher; David Binns; Andrew M Scott; Lester J Peters
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-26       Impact factor: 9.236

4.  Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

Authors:  Susanne-Martina Eschmann; Frank Paulsen; Matthias Reimold; Helmut Dittmann; Stefan Welz; Gerald Reischl; Hans-Juergen Machulla; Roland Bares
Journal:  J Nucl Med       Date:  2005-02       Impact factor: 10.057

5.  pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.

Authors:  Bernd Gagel; Patrick Reinartz; Ercole Dimartino; Michael Zimny; Michael Pinkawa; Payam Maneschi; Sven Stanzel; Kurt Hamacher; Heinz H Coenen; Michael Westhofen; Ulrich Büll; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2004-10       Impact factor: 3.621

6.  Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.

Authors:  Huagang Hou; Nadeem Khan; Julia A O'Hara; Oleg Y Grinberg; Jeff F Dunn; Michelle A Abajian; Carmen M Wilmot; Malek Makki; Eugene Demidenko; Shiyi Lu; Robert P Steffen; Harold M Swartz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-01       Impact factor: 7.038

Review 7.  Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications.

Authors:  Bernard Gallez; Christine Baudelet; Bénédicte F Jordan
Journal:  NMR Biomed       Date:  2004-08       Impact factor: 4.044

8.  Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography.

Authors:  W J Koh; K S Bergman; J S Rasey; L M Peterson; M L Evans; M M Graham; J R Grierson; K L Lindsley; T K Lewellen; K A Krohn
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-09-30       Impact factor: 7.038

Review 9.  Positron emission tomography/computed tomography for target delineation in head and neck cancers.

Authors:  Peter H Ahn; Madhur K Garg
Journal:  Semin Nucl Med       Date:  2008-03       Impact factor: 4.446

10.  Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia.

Authors:  Arnulf Mayer; Michael Höckel; Alexander Wree; Cornelia Leo; Lars-Christian Horn; Peter Vaupel
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701
View more
  2 in total

Review 1.  Non-FDG PET in oncology.

Authors:  R Núñez Miller; M A Pozo
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

Review 2.  PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

Authors:  Egesta Lopci; Ilaria Grassi; Arturo Chiti; Cristina Nanni; Gianfranco Cicoria; Luca Toschi; Cristina Fonti; Filippo Lodi; Sandro Mattioli; Stefano Fanti
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.